Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CC transcript
Bonus plan approved
Inv. presentation
Acq. announced
Director departure
CUBIST PHARMACEUTICALS INC (CBST) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/21/2014 8-K Quarterly results
Docs: "shall be deemed to be furnished, and not filed:"
07/22/2014 8-K Quarterly results
Docs: "shall be deemed to be furnished, and not filed:"
04/22/2014 8-K Quarterly results
Docs: "CUBIST PHARMACEUTICALS REPORTS FIRST QUARTER 2014 FINANCIAL RESULTS",
"Cubist Announces Submission of New Drug Application for Investigational Antibiotic Ceftolozane/tazobactam"
01/23/2014 8-K Quarterly results
Docs: "CUBIST REPORTS FOURTH QUARTER AND FULL YEAR 2013 FINANCIAL RESULTS; PROVIDES 2014 REVENUE GUIDANCE"
10/22/2013 8-K Quarterly results
Docs: "CUBIST REPORTS THIRD QUARTER 2013 FINANCIAL RESULTS"
07/18/2013 8-K Quarterly results
01/23/2013 8-K Form 8-K - Current report
10/18/2012 8-K Quarterly results
Docs: "CUBIST INCREASES REVENUE 18% TO $238 MILLION IN THE THIRD QUARTER"
07/19/2012 8-K Form 8-K - Current report
04/18/2012 8-K Quarterly results
Docs: "CUBIST PHARMACEUTICALS REPORTS FIRST QUARTER 2012 FINANCIAL RESULTS"
01/19/2012 8-K Form 8-K - Current report
10/19/2011 8-K Quarterly results
Docs: "Cubist Pharmaceuticals Total Net Revenues Top $200 Million for Third Quarter 2011"
07/14/2011 8-K Quarterly results
Docs: "Cubist Pharmaceuticals 2Q11 Total Net Revenues $176.8 Million"
01/20/2011 8-K Form 8-K - Current report
10/14/2010 8-K Form 8-K - Current report
07/15/2010 8-K Form 8-K - Current report
04/15/2010 8-K Form 8-K - Current report
01/21/2010 8-K Quarterly results
Docs: "CUBIST PHARMACEUTICALS ANNOUNCES FULL YEAR 2009 TOTAL NET REVENUES OF $562.1 MILLION GAAP DILUTED NET INCOME OF $0.38 PER SHARE IN FOURTH QUARTER GAAP DILUTED NET INCOME OF $1.36 PER SHARE FOR FULL YEAR NON-GAAP DILUTED NET INCOME OF $2.29 PER SHARE FOR FULL YEAR"
10/15/2009 8-K Quarterly results
Docs: "Cubist Pharmaceuticals 3rd Quarter Total Net Revenues Up 28%"
07/16/2009 8-K Quarterly results
Docs: "Cubist Pharmaceuticals 2nd Quarter Total Net Revenues Up 28%"
04/21/2009 8-K Form 8-K -- Current report
01/22/2009 8-K Quarterly results
Docs: "CUBIST PHARMACEUTICALS REPORTS GAAP DILUTED NET INCOME OF $1.82 PER SHARE IN FOURTH QUARTER 2008 AND GAAP DILUTED NET INCOME OF $2.56 PER SHARE FOR FULL YEAR 2008 REVERSAL OF CUBIST'S VALUATION ALLOWANCE FOR DEFERRED TAX ASSETS BENEFITS TAX EXPENSE BY APPROXIMATELY $127.8 MILLION 2008 NON-GAAP DILUTED NET INCOME OF $1.86 PER SHARE Earnings Conference Call & Webcast Today at 5:00 p.m. ET"
10/16/2008 8-K Quarterly results
Docs: "CUBIST PHARMACEUTICALS Q3 2008 REVENUES UP 41%; NET INCOME UP 39%: TOTAL REVENUES $112.4"
07/17/2008 8-K Quarterly results
Docs: "CUBIST PHARMACEUTICALS REPORTS FIRST $100 MILLION REVENUE QUARTER; Q2 2008 TOTAL REVENUES $101.8 MILLION"
04/17/2008 8-K Quarterly results
Docs: "CUBIST PHARMACEUTICALS Q1 2008 REVENUES UP 48%; NET INCOME UP 220%: TOTAL REVENUES $88.3 MILLION; NET PRODUCT REVENUES $87.9 MILLION GAAP Basic and Diluted Net Income of $0.32 and $0.26 Per Share, Respectively NON-GAAP Basic and Diluted Net Income of $0.41 and $0.34 Per Share, Respectively Earnings Conference Call & Webcast Today at 5:00 pm EDT"
01/23/2008 8-K Quarterly results
Docs: "CUBIST PHARMACEUTICALS REPORTS GAAP DILUTED NET INCOME OF $0.16 PER SHARE IN FOURTH QUARTER 2007 AND GAAP DILUTED NET"
10/17/2007 8-K Quarterly results
Docs: "CUBIST PHARMACEUTICALS REPORTS THIRD QUARTER 2007 RESULTS: TOTAL REVENUES $79.8 MILLION; NET PRODUCT REVENUES $76.3 MILLION, +52% VS. GAAP Basic and Diluted Net Income of $0.36 and $0.32 Per Share, Respectively Non-GAAP Basic and Diluted Net Income of $0.41 and $0.36 Per Share, Respectively Earnings Conference Call & Webcast Today at 5:00 pm EDT"
07/18/2007 8-K Quarterly results
Docs: "CUBIST PHARMACEUTICALS REPORTS SECOND QUARTER 2007 RESULTS: TOTAL REVENUES $69.8 MILLION; NET PRODUCT REVENUES $69.5 MILLION,"
04/18/2007 8-K Quarterly results
Docs: "CUBIST PHARMACEUTICALS REPORTS FIRST QUARTER 2007 RESULTS:"
01/24/2007 8-K Quarterly results
Docs: "CUBIST PHARMACEUTICALS REPORTS GAAP BASIC NET INCOME OF $0.10 PER SHARE IN"
10/18/2006 8-K Quarterly results
Docs: "CUBIST PHARMACEUTICALS REPORTS THIRD QUARTER 2006 RESULTS AND FIRST PROFITABLE QUARTER GAAP BASIC AND DILUTED NET INCOME $0.09 PER SHARE"
07/19/2006 8-K Quarterly results
Docs: "CUBIST PHARMACEUTICALS REPORTS SECOND QUARTER 2006 RESULTS; TOTAL REVENUES $47.8 MILLION; NET PRODUCT REVENUES $45.7 MILLION, UP 78% VS. 2Q05 GAAP LOSS $0.09 PER SHARE"
04/19/2006 8-K Quarterly results
Docs: "CUBIST PHARMACEUTICALS REPORTS FIRST QUARTER 2006 RESULTS; TOTAL REVENUES $40.1 MILLION; NET PRODUCT REVENUES $37.9 MILLION GAAP LOSS $0.11 PER SHARE NON-GAAP LOSS $0.06 PER SHARE Earnings Conference Call & Webcast Today at 5:00 pm EDT"
01/23/2006 8-K Quarterly results
Docs: "CUBIST PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2005 RESULTS; FULL YEAR 2005 LOSS PER SHARE TOTALS 60 CENTS Earnings Conference Call & Webcast Today at 5:00 p.m. ET"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy